Contact Us

Chesapeake Urology’s Sankar Kausik, M.D., First in Maryland to Offer Minimally Invasive iTind Procedure for Novel BPH Treatment 

A new minimally invasive way to reshape an enlarged prostate as an alternative to surgery, medications, and permanent implants


Owings Mills, MD (February 1, 2022) – Sankar Kausik, MD, a urologist with Chesapeake Urology in Bel Air, Maryland, was the first in the region to perform the minimally invasive iTind procedure to treat the symptoms of BPH/enlarged prostate. The iTind received FDA de Novo classification as a novel device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH) in February 2020. Dr. Kausik performed the first case in Maryland on January 27, 2022.

“The iTind is a novel, clinically-proven therapy for men suffering from symptoms of an enlarged prostate. The removable implant gently opens the obstruction in the prostate without cutting or heat or need to leave behind a permanent implant. There are also no sexual side effects compared to traditional prostate surgery or even medications.” said Dr. Kausik.

BPH, also known as an enlarged prostate, is one of the most common diseases in aging men and the most common cause of lower urinary tract symptoms (LUTS).[i] According to the American Urological Association, BPH is a condition that 8 out of 10 men will face in their lifetimes, with more than half of men over the age of 50 showing symptoms.[ii]

The iTind procedure reshapes the anatomy of the prostatic urethra, gently creating a wider opening for urine to flow freely, without burning or cutting out tissue, and without leaving behind a permanent implant. The treatment is straightforward, does not require overnight hospitalization, and is a less invasive treatment that has no major side effects, including no sexual side effects.iii

The procedure is typically performed in an office-based setting with a quick recovery and return to work for patients.

For more information about the new BPH treatment using the iTind at Chesapeake Urology, visit iTind for BPH – Chesapeake Urology or www.iTind.com.

To learn more about BPH/enlarged prostate and all treatment options available to men at Chesapeake Urology, visit BPH/Enlarged Prostate – Treatments for BPH – Chesapeake Urology.

[i] Lim KB. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3), 148–151. doi:10.1016/j.ajur.2017.06.004
[ii] Medical Student Curriculum: Benign Prostatic Hyperplasia (BPH). Auanet.org. https://www.auanet.org/education/auauniversity/medical-student-education/medical-student-curriculum/bph. Published May 2013, Updated July 2016. Accessed March 3, 2020.
iii Kadner G, Valerio M, Giannakis I, Manit A, Lumen N, Ho BSH, Alonso S, Schulman C, Barber N, Amparore D, Porpiglia F. Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study. World J Urol. 2020 Mar 2. PMID: 32124019.

Contact Us